Screening of single-donor apheresis platelets for bacterial contamination: The PASSPORT study results

Transfusion

Volumn 50, Issue 3, 2010, Pages 589-599

  Dumont, Larry J ^a   Kleinman, Steven ^a   Murphy, James R ^a   Lippincott, Rebecca ^a   Schuyler, Robert ^a   Houghton, Jaime ^a   Metzel, Peyton ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

APHERESIS; ARTICLE; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; BACTERIUM DETECTION; BLOOD TRANSFUSION REACTION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INFECTION RISK; NONHUMAN; SEPSIS; THROMBOCYTE PRESERVATION; THROMBOCYTE TRANSFUSION;

BACTERIA; BLOOD COMPONENT REMOVAL; BLOOD PLATELETS; BLOOD PRESERVATION; FEMALE; HUMANS; MALE; PLATELET TRANSFUSION; RETROSPECTIVE STUDIES; SAFETY MANAGEMENT; TIME FACTORS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 77649202190     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02460.x     Document Type: Article

References (26)

1. Dumont LJ, AuBuchon JP. Making risk statements stick. Vox Sang 2002 83 : 199 203.
2. Ness P, Braine H, King K, Barrasso C, Kickler T, Fuller A, Blades N. Single-donor platelets reduce the risk of septic platelet transfusion reactions. Transfusion 2001 41 : 857 61.
3. Yomtovian R. Bacterial contamination of blood: lessons from the past and road map for the future. Transfusion 2004 44 : 450 60.
4. Braine HG, Kickler TS, Charache P, Ness PM, Davis J, Reichart C, Fuller AK. Bacterial sepsis secondary to platelet transfusion: an adverse effect of extended storage at room temperature. Transfusion 1986 26 : 391 3.
5. Esber EC. Reduction of the maximum platelet storage period to 5 days in an approved container. FDA memorandum. Rockville (MD) : U.S. Food and Drug Administration 1986.
6. Dumont LJ, AuBuchon JP, Whitley P, Herschel LH, Johnson A, McNeil D, Sawyer S, Roger JC. Seven-day storage of single-donor platelets: recovery and survival in an autologous transfusion study. Transfusion 2002 42 : 847 54.
7. Vassallo R, Murphy S, Einarson M, Nixon J, Ziegler D, Snyder E, Baril L, Dincecco D, Corda T, Carrano D, Greenwalt TJ, Cancelas J, Rugg N, Joines A, Gormas JF, Pratt PG, Lee WJ, Buchholz DH, Elfath MD. Evaluation of platelets stored for 8 days in PL 2410 containers. Transfusion 2004 44 Suppl : 28A.
8. Slichter SJ, Bolgiano D, Jones MK, Christoffel T, Corson J, Rose L, Foley J, Popovsky M, Baril LL, Corda T, Dincecco DM, Snyder EL. Viability and function of 8-day-stored apheresis platelets. Transfusion 2006 46 : 1763 9.
9. Fridey JL, editor. Standards for blood banks and transfusion services. 22nd ed. Bethesda (MD) : American Association of Blood Banks 2003. p. 13.
10. Brecher ME, Hay SN, Rothenberg SJ. Evaluation of a new generation of plastic culture bottles with an automated microbial detection system for nine common contaminating organisms found in PLT components. Transfusion 2004 44 : 359 63.
11. McDonald CP, Rogers A, Cox M, Smith R, Roy A, Robbins S, Hartley S, Barbara JA, Rothenberg S, Stutzman L, Widders G. Evaluation of the 3D BacT/ALERT automated culture system for the detection of microbial contamination of platelet concentrates. Transfus Med 2002 12 : 303 9.
12. Munksgaard L, Albjerg L, Lillevang ST, Gahrn-Hansen B, Georgsen J. Detection of bacterial contamination of platelet components: six years' experience with the BacT/ALERT system. Transfusion 2004 44 : 1166 73.
13. Sazama K, Lipton K. Actions following an initial positive test for possible bacterial contamination of a platelet unit. AABB Association Bulletin #04-07. October 14, 2004.
14. O'Brien T, Jacobson JL, McQuail E, Strauss D. Implementation of 7-day single donor platelets. Transfusion 2006 46 Suppl : 171A.
15. Public Health Agency of Canada. Guideline for investigation of suspected transfusion transmitted bacterial contamination. CCDR 2008 34S1 : 1 8. Available from: http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/08pdf/34S1-eng.pdf
16. Benjamin RJ, Wagner SJ. The residual risk of sepsis: modeling the effect of concentration on bacterial detection in two-bottle culture systems and an estimation of false-negative culture rates. Transfusion 2007 47 : 1381 9.
17. Katz L, Rasso M, McCullough J. Economic impact of suspension of PASSPORT and reversion to 5-day apheresis platelet dating. Transfusion 2008 48 Suppl : 111A.
18. Kleinman S, Dumont LJ, Tomasulo P, Bianco C, Katz L, Benjamin RJ, Gajic O, Brecher ME. The impact of discontinuation of 7-day storage of apheresis platelets (PASSPORT) on recipient safety: an illustration of the need for proper risk assessments. Transfusion 2009 49 : 903 12.
19. Murphy WG, Foley M, Doherty C, Tierney G, Kinsella A, Salami A, Cadden E, Coakley P. Screening platelet concentrates for bacterial contamination: low numbers of bacteria and slow growth in contaminated units mandate an alternative approach to product safety. Vox Sang 2008 95 : 13 9.
20. Eder AF, Kennedy JM, Dy BA, Notari EP, Weiss JW, Fang CT, Wagner S, Dodd RY, Benjamin RJ. Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006). Transfusion 2007 47 : 1134 42.
21. Eder AF, Kennedy JM, Dy BA, Notari EP, Skeate R, Bachowski G, Mair DC, Webb JS, Wagner SJ, Dodd RY, Benjamin RJ. Limiting and detecting bacterial contamination of apheresis platelets: inlet-line diversion and increased culture volume improve component safety. Transfusion 2009 49 : 1554 63.
22. de Korte D, Curvers J, de Kort WL, Hoekstra T, van der Poel CL, Beckers EA, Marcelis JH. Effects of skin disinfection method, deviation bag, and bacterial screening on clinical safety of platelet transfusions in the Netherlands. Transfusion 2006 46 : 476 85.
23. FDA. Fatalities reported to FDA following blood collection and transfusion. Annual summary for fiscal year 2008. Rockville (MD) : Food and Frug Administration. Available from: http://www.fda.gov/cber
24. Carter S, Scott S. Evaluation of commercially prepared bacteria panel for validation of post-storage bacterial detection tests in platelet. Transfusion 2008 48 Suppl : 112A.
25. Osselaer JC, Messe N, Hervig T, Bueno J, Castro E, Espinosa A, Accorsi P, Junge K, Jacquet M, Flament J, Corash L. A prospective observational cohort safety study of 5106 platelet transfusions with components prepared with photochemical pathogen inactivation treatment. Transfusion 2008 48 : 1061 71.
26. Goodrich RP, Gilmour D, Hovenga N, Keil SD. A laboratory comparison of pathogen reduction technology treatment and culture of platelet products for addressing bacterial contamination concerns. Transfusion 2009 49 : 1205 16.